ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
ResMed (RMD) Tops Q4 EPS by 25c
August 5, 2020 4:38 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $1.33, $0.25 better than the analyst estimate of $1.08. Revenue for the quarter came in at $770.3 million versus the consensus estimate of $746.9 million.
Our fourth quarter results reflect the strength and resiliency of our business in todays uncertain environment. We finished... More
